feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Airbus A320 software update ordered

trending

MLA Kanathil Jameela dies

trending

Foden bails Manchester City out

trending

Babar Azam cherishes India win

trending

PSG loses Ligue 1 game

trending

Newcastle dominates Everton away

trending

Xbox Cloud Gaming Outage

trending

Tree branch falls on cars

trending

Verstappen admits Red Bull problem

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / India's 'One Health' Initiative: New Surveillance Hub Launched

India's 'One Health' Initiative: New Surveillance Hub Launched

28 Nov

•

Summary

  • RGCB selected as a national hub for genomic surveillance.
  • Programme tackles undiagnosed febrile illnesses and infections.
  • Initiative strengthens India's preparedness for future outbreaks.
India's 'One Health' Initiative: New Surveillance Hub Launched

The Rajiv Gandhi Centre for Biotechnology (RGCB) has been appointed as one of four national hubs for next-generation sequencing (NGS) within the Metagenomic Syndromic Surveillance Programme. This vital initiative operates under the National 'One Health Mission' and is designed to confront the persistent challenge of undiagnosed acute febrile illnesses, encephalitis, diarrhoeal diseases, and respiratory infections. The programme's advanced capabilities will allow for the simultaneous detection of known, rare, and novel pathogens that often evade traditional diagnostic methods.

In collaboration with leading institutions like CCMB and TIGS, the RGCB will utilize its Bio Safety Level-3 facility and cutting-edge sequencing technology. As the designated NGS hub for acute febrile illness, the RGCB will focus on viral genomics and host-pathogen interactions. Analyzing a vast number of samples from national surveillance sites, the centre aims to pinpoint the elusive etiological agents behind India's common yet unresolved clinical conditions.

This nationwide consortium promises to generate significant insights into India's infectious disease landscape, bolstering epidemic intelligence and supporting the development of indigenous diagnostic tools tailored to local pathogen diversity. The effort marks a substantial stride towards a unified 'One Health' framework, integrating human, animal, and environmental health surveillance to bolster India's resilience against future outbreaks and pandemics.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The RGCB has been selected as a national next-generation sequencing (NGS) hub for the Metagenomic Syndromic Surveillance Programme.
The programme aims to address undiagnosed acute febrile illness, encephalitis, diarrhoeal diseases, and respiratory infections.
By identifying rare and novel pathogens, the hub will enhance epidemic intelligence and preparedness against future outbreaks.

Read more news on

Healthside-arrow

You may also like

IIT Delhi Invents Washable Mosquito Repellent

27 Nov • 9 reads

Biotech Chief Proposes Drug Approval Overhaul

24 Nov • 6 reads

article image

India Develops Affordable Disease Treatment

21 Nov • 41 reads

article image

WHO Greenlights Pneubevax 14 for Global Use

21 Nov • 59 reads

article image

Gurugram Residents Struggle with Hazardous Air Quality

16 Nov • 47 reads

article image